back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-07-28 Tx date 2017-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-29,000 vol |
172,772 | |
| Filed 2017-07-28 Tx date 2017-07-28 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,509.3216
-10,804 vol $1.25 each |
107,779 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,960
+29,000 vol $1.24 each |
118,583 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+83,192 vol |
201,772 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+96,121 vol |
136,217 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+130,380 vol |
209,327 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,544.05
-5,205 vol $2.41 each |
89,583 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-35,525.25
-15,789 vol $2.25 each |
118,580 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,525
+15,789 vol $2.25 each |
94,788 | |
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$102,656
+28,999 vol $3.54 each |
78,999 | |
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$102,656
+28,999 vol $3.54 each |
||
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-102,656.46
-28,999 vol $3.54 each |
||
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-102,656.46
-28,999 vol $3.54 each |
134,369 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$174,495
+50,000 vol $3.49 each |
50,000 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+47,368 vol |
163,368 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+78,947 vol |
78,947 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,096 vol |
40,096 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,863 vol |
116,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
29,137 |